HAMID ESKANDARI: Open Payments
NPI 1063662682 · FOOTHILL RANCH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 6 payments from 5 companies in 2025. Trend: 2023 $255 · 2024 $303 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $117 |
| AstraZeneca Pharmaceuticals LP | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 1 | $38 |
| Lundbeck LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: REXULTI, AIRSUPRA, HETLIOZ, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
